Resistance Profile of Neisseria gonorrhoeae in KwaZulu-Natal, South Africa Questioning the Effect of the Currently Advocated Dual Therapy
Conclusions
The current syndromic management with dual ceftriaxone and azithromycin is due to the high level of azithromycin resistance factually single-drug therapy. High-level tetracycline resistance based on a resistance mechanism other than ribosome protection by the tetM gene product is present in N. gonorrhoeae infecting South African patients.
Source: Sexually Transmitted Diseases - Category: Sexual Medicine Tags: Original Studies Source Type: research
More News: Antimicrobial Resistance | Azithromycin | Carbohydrates | Ceftriaxone | Genetics | Netherlands Health | Rocephin | Sexual Medicine | South Africa Health | STDs | Study | Tetracycline | Zithromax